Neopharm Group

Neopharm Group Overview

Neopharm is a family of companies that engage in the research and development, manufacturing, marketing, sales, and distribution of a broad range of products in the healthcare market in more than 60 countries worldwide. The Neopharm Group operates in three major segments: pharmaceutical, consumer healthcare, and medical devices.

Latest News

Mar 17, 2023 · www.pharmaceutical-technology.com

growth-positive

Amylyx and Neopharm sign licence agreement for ALS therapy

Amylyx Pharmaceuticals has signed a license and distribution agreement with Neopharm to commercialize AMX0035 for the treatment of amyotrophic lateral sclerosis (ALS). Neopharm will have exclusive rights to commercialize the therapy in Israel, West Bank, Gaza, and the Palestinian Authority. The agreement will help expand the availability of AMX0035 in the EMEA region if approved. AMX0035 has already received approval in the US and Canada, and the European Medicines Agency is reviewing its application for approval in Europe. The partnership with Neopharm will aid in reaching eligible ALS patients more quickly and efficiently.

Partners

Funding

Team Members

4

Employees: 51-200

Web & Social Links

Locations

HaShiloah St 6, Petah Tikva, Israel

Photos & Videos

No files yet

Neopharm Group Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info